U S Department of Health and Human Services www.hhs.gov
Centers for Medicare & Medicaid Services
Draft ICD-10-CM/PCS MS-DRGv28 Definitions Manual Previous Page [Alt-p] Up a level [Alt-u] Next Page [Alt-n]
MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Chemotherapy
SDX Acute Leukemia High Dose Chemo Agent MCC CC DRG
Yes n/a Yes n/a 837
No Yes Yes n/a 837
Yes No No Yes 838
No Yes No n/a 838
Yes No No No 839

DRG 837 CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC

DRG 838 CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT

DRG 839 CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC

CHEMOTHERAPY

PRINCIPAL DIAGNOSIS

Z08Encounter for follow-up examination after completed treatment for malignant neoplasm
Z5111Encounter for antineoplastic chemotherapy
Z5112Encounter for antineoplastic immunotherapy

ACUTE LEUKEMIA

SECONDARY DIAGNOSIS

C9100Acute lymphoblastic leukemia not having achieved remission
C9101Acute lymphoblastic leukemia, in remission
C9102Acute lymphoblastic leukemia, in relapse
C9200Acute myeloblastic leukemia, not having achieved remission
C9201Acute myeloblastic leukemia, in remission
C9202Acute myeloblastic leukemia, in relapse
C9240Acute promyelocytic leukemia, not having achieved remission
C9241Acute promyelocytic leukemia, in remission
C9242Acute promyelocytic leukemia, in relapse
C9250Acute myelomonocytic leukemia, not having achieved remission
C9251Acute myelomonocytic leukemia, in remission
C9252Acute myelomonocytic leukemia, in relapse
C9260Acute myeloid leukemia with 11q23-abnormality not having achieved remission
C9261Acute myeloid leukemia with 11q23-abnormality in remission
C9262Acute myeloid leukemia with 11q23-abnormality in relapse
C92A0Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
C92A1Acute myeloid leukemia with multilineage dysplasia, in remission
C92A2Acute myeloid leukemia with multilineage dysplasia, in relapse
C9300Acute monoblastic/monocytic leukemia, not having achieved remission
C9301Acute monoblastic/monocytic leukemia, in remission
C9302Acute monoblastic/monocytic leukemia, in relapse
C9400Acute erythroid leukemia, not having achieved remission
C9401Acute erythroid leukemia, in remission
C9402Acute erythroid leukemia, in relapse
C9500Acute leukemia of unspecified cell type not having achieved remission
C9501Acute leukemia of unspecified cell type, in remission
C9502Acute leukemia of unspecified cell type, in relapse

HIGH DOSE CHEMO AGENT

NON-OPERATING ROOM PROCEDURE

3E03002Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach
3E03302Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach
3E04002Introduction of High-dose Interleukin-2 into Central Vein, Open Approach
3E04302Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach
3E05002Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach
3E05302Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach
3E06002Introduction of High-dose Interleukin-2 into Central Artery, Open Approach
3E06302Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach
3E0R302Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
3E0S302Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach



Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244